This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEC0K08U_M.jpg
As a result, value stocks are back in the limelight after underperforming the broader market last year. This is evidenced by the SPDR Portfolio S&P 500 Value ETF’s (SPYV) 14.2% returns over the past three months versus the SPDR Portfolio S&P 500 Growth ETF’s (SPYG) 4.1% gains. While the economy has begun to recover in the United States, the health crisis is far from over and there is still a sense of uncertainty in the markets. Experts also worry that another stock market correction could be in the offing. Therefore, picking fundamentally strong undervalued stocks could be a smart strategy at this juncture.
We believe Hologic, Inc. (HOLX), AGCO Corporation (AGCO), Bausch Health Companies Inc. (BHC), and United Therapeutics Corporation (UTHR) are solid value bets now.
